Drug and Medication Analysis & Statistics in South Korea, April 2014 (p2)

You might be interested in: Drug, Vaccine, Smoking Cessation, more »

31-52 of 52 reports

Purchase Reports From Reputable Market Research Publishers

CMG Pharmaceutical Co., Ltd. (058820) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

CMG Pharmaceutical Co., Ltd. (058820) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • April 2014
  • by Global Data

Summary CMG Pharmaceutical Co., Ltd. (CMG Pharmaceutical) is a pharmaceutical company, based in Korea. The company manufactures and sells pharmaceutical, health food and non-pharmaceutical products. It ...

  • Industries : Drug and Medication
  • Countries : South Korea
Orphan Drugs in Asia 2014

Orphan Drugs in Asia 2014

  • $ 1 500
  • Industry report
  • March 2014
  • by Pacific Bridge Medical

Following the example of the US FDA's Orphan Drug Act established in 1983, some Asian countries have developed orphan drug legislations, such as Singapore's Orphan Drug Exemption to the Medicines Act and ...

  • Industries : Drug and Medication
  • Countries : Asia, Japan, South Korea, Taiwan, China, World, Philippines, Singapore, United States, Malaysia, Vietnam, Thailand
South Korea Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

South Korea Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • February 2014
  • by Business Monitor International

BMI View: While South Korea's research and development (R&D) environment may be attractive to investors, its pharmaceutical industry environment is rather uncertain given the dispute between pharmaceutical ...

  • Industries : Drug and Medication
  • Countries : South Korea
South Korea Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

South Korea Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • December 2013
  • by Business Monitor International

BMI View: Unlike some observers, BMI classes South Korea as a developed country and this is underpinned by the balanced risk/reward profile of its pharmaceutical industry . Negative attributes include ...

  • Industries : Drug and Medication
  • Countries : South Korea
Daewon Pharmaceutical Co., Ltd. (003220) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Daewon Pharmaceutical Co., Ltd. (003220) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary Daewon Pharmaceutical Co., Ltd. (Daewon) is a pharmaceutical service provider, based in Republic of Korea. The company develops, produces and markets pharmaceutical products. Its products include ...

  • Industries : Drug and Medication
  • Countries : South Korea
Ear Care Market Analysis in South Korea

Ear Care Market Analysis in South Korea

  • $ 898
  • Industry report
  • July 2013
  • by Euromonitor International

South Koreans tend to consult a doctor for ear, eye and throat problems, and OTC ear care products are not available in the country. Euromonitor International's report offers a comprehensive guide to the ...

  • Industries : Drug and Medication
  • Countries : South Korea
Vaccines - Global Markets Package

Vaccines - Global Markets Package

  • $ 24 060
  • Industry report
  • May 2013
  • by Global Research & Data Services

This industry data report package offers a perspective on the actual market situation, trends and future outlook for vaccines in different countries around the world. The reports provide essential market ...

  • Industries : Drug and Medication
  • Countries : World, Europe, Asia, South America, Czech Republic, South Korea, Philippines, Africa, Australia, Argentina, United States, United Kingdom, Netherlands, Macedonia, Lithuania, Sri Lanka, Singapore, Kazakhstan, Indonesia, Bangladesh, Azerbaijan, South Africa, Uruguay, Ecuador, Chile, Colombia, Bolivia, Panama, Mexico, Canada, Ukraine, Sweden, Spain, Slovenia, Slovakia (slovak Republic), Russian Federation, Romania, Portugal, Poland, Norway, Moldova, Republic Of, Latvia, Italy, Ireland, Hungary, Greece, France, Germany, Finland, Estonia, Denmark, Bulgaria, Belgium, Austria, Thailand, Pakistan, Nepal, Mongolia, Malaysia, Lebanon, Jordan, Japan, India, China, Georgia, Armenia, Sudan, Senegal, Nigeria, Morocco, Ghana, Ethiopia, Egypt, Kyrgyz Republic (kyrgyzstan), North America, Peru, Oman, Iran
Vaccine Market in South Korea

Vaccine Market in South Korea

  • $ 652
  • Industry report
  • May 2013
  • by Global Research & Data Services

This industry data report offers a perspective on the actual market situation, trends and future outlook for vaccines in South Korea. The report provides essential market data for decision-makers including: ...

  • Industries : Drug and Medication
  • Countries : South Korea
MarketVIEW: Hepatitis C virus vaccines

MarketVIEW: Hepatitis C virus vaccines

  • $ 9 995
  • Industry report
  • February 2013
  • by VacZine Analytics Group Of Assay Advantage Ltd

Hepatitis C is caused by infection with the Hepatitis C virus (HCV). Transmission is predominately through the blood-to blood route where persons such as current or former injection drug users, past recipients ...

  • Industries : Drug and Medication
  • Countries : South Korea, Australia
Korean Drug Co., Ltd. (14570) - Company Capsule

Korean Drug Co., Ltd. (14570) - Company Capsule

  • $ 75
  • Company report
  • November 2012
  • by World Market Intelligence Ltd

Synopsis WMI's 'Korean Drug Co., Ltd. (14570) - Company Capsule' contains a company overview, key facts, key employees, products and services, key competitors, locations and subsidiaries as well as financial ...

  • Industries : Drug and Medication
  • Countries : South Korea
MarketVIEW: hepatitis A vaccines (travel)

MarketVIEW: hepatitis A vaccines (travel)

  • $ 5 995
  • Industry report
  • October 2012
  • by VacZine Analytics Group Of Assay Advantage Ltd

Hepatitis A (HAV) produces a self-limiting liver disease which can produce a range of symptoms such as nausea, anorexia, fever, malaise or abdominal pain. Unlike Hepatitis B and C viruses it does not cause ...

  • Industries : Drug and Medication
  • Countries : United States, North America, World, South Korea, Europe, Australia, Brazil, Canada, United Kingdom, Sweden, Spain, Norway, Italy, France, Germany, Finland, Denmark
Yuhan Corporation (100) : Company Profile and SWOT Analysis

Yuhan Corporation (100) : Company Profile and SWOT Analysis

  • $ 125
  • Company report
  • July 2012
  • by World Market Intelligence Ltd

Synopsis World Market Intelligence's 'Yuhan Corporation (100) : Company Profile and SWOT Analysis' contains in depth information and data about the company and its operations. The profile contains a company ...

  • Industries : Drug and Medication
  • Countries : South Korea
Orphan Drugs in Asia 2012: Guidelines and Regulatory Requirements to Help Orphan Drug Products Enter the Asian Market 2012

Orphan Drugs in Asia 2012: Guidelines and Regulatory Requirements to Help Orphan Drug Products Enter the Asian Market 2012

  • $ 1 500
  • Industry report
  • April 2012
  • by Pacific Bridge Medical

Historically, many drugs for rare diseases were developed to fulfill the needs of public health, rather than for drug companies' financial gain. Nevertheless, there is now a growing awareness of rare diseases ...

  • Industries : Drug and Medication
  • Countries : Asia, Japan, Taiwan, South Korea, China, World, Philippines, Singapore, Malaysia, United States, Vietnam, Thailand
Guidelines and Regulatory Requirements to Help Orphan Drug Products Enter the Asian Market

Guidelines and Regulatory Requirements to Help Orphan Drug Products Enter the Asian Market

  • $ 1 500
  • Industry report
  • April 2012
  • by Pacific Bridge Medical

Overview: Following the example of the US FDA's Orphan Drug Act established in 1983, some Asian countries have developed orphan drug legislations, such as Singapore's Orphan Drug Exemption to the Medicines ...

  • Industries : Drug and Medication
  • Countries : Asia, Japan, South Korea, Taiwan, China, World, Philippines, Singapore, United States, Malaysia
Menarini Group: Pharmaceuticals and Healthcare Company Profile & SWOT Report

Menarini Group: Pharmaceuticals and Healthcare Company Profile & SWOT Report

  • $ 125
  • Company report
  • February 2012
  • by ICD Research

Synopsis ICD Research's "Menarini Group: Pharmaceuticals and Healthcare Company Profile & SWOT Report" contains in depth information and data about the company and its operations. The profile contains ...

  • Industries : Drug and Medication
  • Countries : Italy, Europe, Switzerland, South Africa, World, Vietnam, South Korea, India, China
MarketVIEW: universal pneumo vaccines

MarketVIEW: universal pneumo vaccines

  • $ 9 995
  • Industry report
  • January 2012
  • by VacZine Analytics Group Of Assay Advantage Ltd

Vaccines to prevent serious infections caused by Streptococcus pneumoniae or "pneumo" currently form the largest component of the global vaccine market ($4 - 5bn/yr). Notable examples are Prevnar/Prevena ...

  • Industries : Drug and Medication
  • Countries : South Korea, Europe, World, Australia, Netherlands, United States, Canada, Spain, Portugal, Poland, Italy, Greece, France, Germany, Belgium, Japan, United Kingdom, Bangladesh, Brazil, Mexico, Gambia
Spices & Stimulants Market Overview in South Korea

Spices & Stimulants Market Overview in South Korea

  • $ 350
  • Industry report
  • April 2011
  • by MarketLine

The profile also contains descriptions of the key companies including key financial metrics and analysis of competitive pressures within the industry . Essential resource for top-line data and analysis ...

  • Industries : Drug and Medication
  • Countries : South Korea
Financial Health of Biotechnology and Drugs Companies in Rest of Asia

Financial Health of Biotechnology and Drugs Companies in Rest of Asia

  • $ 6 500
  • Industry report
  • December 2010
  • by Frost & Sullivan

The research services examines the financial performance of biotechnology companies across Rest of Asia across 2 broad parameters- Excellence in financial management and Excellence in risk management. ...

  • Industries : Drug and Medication
  • Countries : Asia, South Korea, Japan, World, Indonesia
UCB:  Pipeline - Products ? Performance - Potential

UCB: Pipeline - Products ? Performance - Potential

  • $ 1 006
  • Company report
  • January 2010
  • by Espicom Business Intelligence

UCB is a global biopharmaceutical company dedicated to the research, development and commercialisation of innovative pharmaceutical and biotechnology products in the fields of CNS disorders, allergy/respiratory ...

  • Industries : Drug and Medication, Pharmaceutical
  • Countries : Europe, South Korea, Belgium, World, Switzerland, United States, Spain, Italy, Germany, Japan, India
Multi-client Study: Opportunities Assessment for the Hepatitis C Therapeutics Market in South Korea

Multi-client Study: Opportunities Assessment for the Hepatitis C Therapeutics Market in South Korea

  • $ 6 000
  • Industry report
  • December 2009
  • by Frost & Sullivan

This research service aims to provide an update on the epidemiology of Hepatitis C, including the prevalence and incidence, Market Engineering measurements, and government initiatives. It also covers patient ...

  • Industries : Therapy, Drug and Medication
  • Countries : South Korea
Systemic Fungal Infection Therapeutics Market - South Korea

Systemic Fungal Infection Therapeutics Market - South Korea

  • $ 6 000
  • Industry report
  • October 2009
  • by Frost & Sullivan

This research service aims to provide an update on the epidemiology of systemic fungal infection, current diagnostic and treatment practices, as well as market landscape in terms of major participants ...

  • Industries : Therapy, Drug and Medication
  • Countries : South Korea
Rheumatoid Arthritis Therapeutics Market in South Korea

Rheumatoid Arthritis Therapeutics Market in South Korea

  • $ 6 000
  • Industry report
  • March 2009
  • by Frost & Sullivan

This research service aims to provide an update on the epidemiology of rheumatoid arthritis, current diagnostic and treatment practices, as well as market landscape in terms of major participants and future ...

  • Industries : Therapy, Drug and Medication
  • Countries : South Korea

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.